Abenhaim, Lucien

Use of oral corticosteroids and risk of fractures

Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchAdrenal Hormones and Disorders

Cited by 1,263

Appetite-suppressant drugs and the risk of primary pulmonary hypertension

Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine

Pulmonary Hypertension Research and TreatmentsPharmacology and Obesity Treatment

Cited by 1,162

Rates of hypoglycemia in users of sulfonylureas

Van Staa, T., Abenhaim, L., & Monette, J. (1997) · Journal of Clinical Epidemiology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 211

The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization

Nordon, C., Karcher, H., Groenwold, R. H. H., Ankarfeldt, M. Z., Pichler, F., Chevrou-Severac, H., Rossignol, M., Abbe, A., & Abenhaim, L. (2016) · Value in Health

Health Systems, Economic Evaluations, Quality of LifeStatistical Methods in Clinical Trials

Cited by 177

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance.

Grimaldi-Bensouda, L., Rossignol, M., Koné-Paut, I., Krivitzky, A., Lebrun-Frenay, C., Clet, J., Brassat, D., Papeix, C., Nicolino, M., Benhamou, P.-Y., et al. (2017) · Journal of Autoimmunity

Cervical Cancer and HPV ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 84